Clinical Trial Update: Green Tea and Quercetin in Combination With Docetaxel Chemotherapy in Castration-resistant Prostate Cancer Patients [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial is investigating the combination of docetaxel chemotherapy with green tea extract and quercetin in metastatic castration-resist…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Green Tea Extract (Camellia sinensis extract)
• Quercetin (quercetin)

Snippet

Sponsor: Charles Drew University of Medicine and Science | Conditions: Metastatic Castration-resistant Prostate Cancer (mCRPC) | Phase 1, Phase 2 | Status: RECRUITING